⌘K

Login Start Free

Home/Filings/4/0001415889-23-015946

4//SEC Filing

Murray Christopher K. 4

Accession 0001415889-23-015946

CIK 0001597264other

View on SEC.gov Company Profile

Filed

Dec 5, 7:00 PM ET

Accepted

Dec 6, 8:45 PM ET

Size

12.4 KB

Accession

0001415889-23-015946

Insider Transaction Report

Form 4

Period: 2023-12-04

Blueprint Medicines CorpBPMC

Murray Christopher K.

SVP, Technical Operations

Transactions

Sale
Common Stock
2023-12-04$71.43/sh−600$42,858→ 24,495 total

Footnotes (1)

[F1]Effected pursuant to a trading plan adopted on June 5, 2023 pursuant to Rule 10b5-1 under the Securities Exchange Act of 1934, as amended.

Documents

2 files

Issuer

Blueprint Medicines Corp

CIK 0001597264

Entity typeother

Related Parties

1

filerCIK 0001718648

Filing Metadata

Form type: 4
Filed: Dec 5, 7:00 PM ET
Accepted: Dec 6, 8:45 PM ET
Size: 12.4 KB

View on SEC.gov